Authors:
SREDNI B
SHANI A
SHAPIRA J
BRUDERMAN I
ALBECK M
KALECHMAN Y
TICHLER T
Citation: B. Sredni et al., BONE-MARROW SPARING AND PREVENTION OF ALOPECIA BY ASIOI IN A RANDOMIZED PHASE-II STUDY ON NSCL CANCER-PATIENTS TREATED WITH CARBOPLATIN ANDVP-16, Experimental hematology, 23(8), 1995, pp. 858-858
Authors:
COHEN I
BEYTH Y
TEPPER R
FIGER A
SHAPIRA J
CORDOBA M
YIGAEL D
ALTARAS MM
Citation: I. Cohen et al., ADENOMYOSIS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN - A NEW ENTITY, Gynecologic oncology, 58(1), 1995, pp. 86-91
Authors:
COHEN I
TEPPER R
ROSEN DJD
SHAPIRA J
CORDOBA M
DROR Y
ALTARAS M
BEYTH Y
Citation: I. Cohen et al., CONTINUOUS TAMOXIFEN TREATMENT IN ASYMPTOMATIC, POSTMENOPAUSAL BREAST-CANCER PATIENTS DOES NOT CAUSE AGGRAVATION OF ENDOMETRIAL PATHOLOGIES(VOL 55, PG 138, 1994), Gynecologic oncology, 56(2), 1995, pp. 323-323
Citation: J. Shapira et al., EFFECTIVENESS OF MIDAZOLAM AND HYDROXYZINE ON PEDIATRIC DENTAL PATIENTS, Journal of dental research, 74(3), 1995, pp. 963-963
Authors:
KLEIN B
LEVIN I
LURIE H
NYSKA A
SHAPIRA J
KRAVITS M
KLEIN T
Citation: B. Klein et al., ELEVATED PRETREATMENT LEVELS OF SOLUBLE CD8 AND BETA-2-MICROGLOBULIN AS INDICATORS OF RELAPSE IN BREAST-CANCER PATIENTS, International journal of oncology, 4(2), 1994, pp. 471-474
Authors:
LEVIN I
KLEIN T
KUPERMAN O
SEGAL S
SHAPIRA J
GAL R
HART Y
KLEIN B
Citation: I. Levin et al., THE EXPRESSION OF HLA CLASS-I ANTIGEN IN PROSTATE-CANCER IN RELATION TO TUMOR DIFFERENTIATION AND PATIENT SURVIVAL, Cancer detection and prevention, 18(6), 1994, pp. 443-445
Authors:
TEPPER R
COHEN I
ALTARAS M
SHAPIRA J
CORDOBA M
DROR Y
BEYTH Y
Citation: R. Tepper et al., DOPPLER FLOW EVALUATION OF PATHOLOGICAL ENDOMETRIAL CONDITIONS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Journal of ultrasound in medicine, 13(8), 1994, pp. 635-640
Authors:
COHEN I
TEPPER R
ROSEN DJD
SHAPIRA J
CORDOBA M
DROR Y
ALTARAS M
BEYTH Y
Citation: I. Cohen et al., CONTINUOUS TAMOXIFEN TREATMENT IN ASYMPTOMATIC, POSTMENOPAUSAL BREAST-CANCER PATIENTS DOES NOT CAUSE AGGRAVATION OF ENDOMETRIAL PATHOLOGIES, Gynecologic oncology, 55(1), 1994, pp. 138-143
Authors:
COHEN I
TEPPER R
ROSEN DJD
SHAPIRA J
CORDOBA M
DROR Y
ALTARAS M
BEYTH Y
Citation: I. Cohen et al., CONTINUOUS TAMOXIFEN TREATMENT IN ASYMPTOMATIC, POSTMENOPAUSAL BREAST-CANCER PATIENTS DOES NOT CAUSE AGGRAVATION OF ENDOMETRIAL PATHOLOGIES, Gynecologic oncology, 55(1), 1994, pp. 138-143
Authors:
COHEN I
ROSEN DJD
SHAPIRA J
CORDOBA M
GILBOA S
ALTARAS MM
YIGAEL D
BEYTH Y
Citation: I. Cohen et al., ENDOMETRIAL CHANGES WITH TAMOXIFEN - COMPARISON BETWEEN TAMOXIFEN-TREATED AND NONTREATED ASYMPTOMATIC, POSTMENOPAUSAL BREAST-CANCER PATIENTS, Gynecologic oncology, 52(2), 1994, pp. 185-190
Citation: Y. Melamed et al., CONSERVATIVE MULTIDISCIPLINARY TREATMENT APPROACH IN AN UNUSUAL ODONTODYSPLASIA, Journal of dentistry for children, 61(2), 1994, pp. 119-124
Authors:
PERETZ B
SHAPIRA J
FARBSTEIN H
ARIELI E
SMITH P
Citation: B. Peretz et al., MORPHOLOGIC DIFFERENCES BETWEEN MOLARS OF DOWN-SYNDROME AND NORMAL INDIVIDUALS, Journal of dental research, 73, 1994, pp. 445-445
Authors:
COHEN I
ROSEN DJD
ALTARAS M
BEYTH Y
SHAPIRA J
YIGAEL D
Citation: I. Cohen et al., TAMOXIFEN TREATMENT IN PREMENOPAUSAL BREAST-CANCER PATIENTS MAY BE ASSOCIATED WITH OVARIAN OVERSTIMULATION, CYSTIC FORMATIONS AND FIBROID OVERGROWTH, British Journal of Cancer, 69(3), 1994, pp. 620-621
Authors:
COHEN I
ROSEN DJD
SHAPIRA J
CORDOBA M
GILBOA S
ALTARAS MM
YIGAEL D
BEYTH Y
Citation: I. Cohen et al., ENDOMETRIAL CHANGES IN POSTMENOPAUSAL WOMEN TREATED WITH TAMOXIFEN FOR BREAST-CANCER, British journal of obstetrics and gynaecology, 100(6), 1993, pp. 567-570